PS1427 THE SIGNIFICANCE OF UNEXPECTED PHARMACOKINETICS OF DARATUMUMAB DURING LONG-TERM MONTHLY TREATMENT FOR MYELOMA

Autor:	J. Sheldon, A. Crichlow, R. Powles, L. Little
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Pharmacokinetics business.industry Internal medicine Medicine Daratumumab Hematology business Term (time)
Zdroj:	HemaSphere. 3:657
ISSN:	2572-9241
DOI:	10.1097/01.hs9.0000563984.67252.85
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::04985dc9248fc17a9e17fc11bdbe80f3 https://doi.org/10.1097/01.hs9.0000563984.67252.85 Zobrazit plný text záznamu Plný text